Literature DB >> 20978901

Pathological correlates of frontotemporal lobar degeneration in the elderly.

Atik Baborie1, Timothy D Griffiths, Evelyn Jaros, Ian G McKeith, David J Burn, Anna Richardson, Raffaele Ferrari, Jorge Moreno, Parastoo Momeni, Daniel Duplessis, Piyali Pal, Sara Rollinson, Stuart Pickering-Brown, Jennifer C Thompson, David Neary, Julie S Snowden, Robert Perry, David M A Mann.   

Abstract

Frontotemporal lobar degeneration (FTLD) is generally recognised as a disorder with presenile onset (that is before 65 years of age) with only occasional cases presenting later than this. We set out to determine what proportion of cases of FTLD had late onset of disease and whether such cases of FTLD had distinctive clinical and neuropathological features as compared to cases with presenile onset. Within a combined Manchester and Newcastle autopsy series of 117 cases with pathologically confirmed FTLD (109/117 cases also met Lund Manchester clinical criteria for FTLD), we identified 30 cases (onset age range 65-86 years), comprising 25% of all FTLD cases ascertained in these two centres over a 25-year period. Neuropathologically, the 30 elderly cases presented features of several FTLD histological subgroups [FTLD-TDP (types 1, 2 and 3, 19 cases (63%)], FLTD-tau [MAPT, PiD and CBD, 10 cases (33%)] and FTLD-UPS (1 case), similar in range of phenotypes to that seen in the presenile group, though patients with MAPT, but not PGRN, mutation, or FUS pathology, were notably absent or fewer in the elderly group. Hippocampal sclerosis (HS) was present in 13/30 of the elderly FTLD cases (43%) compared with 14/79 (18%) (P = 0.012) in the presenile FTLD patients. Lobar atrophy present in most of the younger patients was prominent in only 25% of the elderly subjects. Prospective and retrospective psychiatric and medical case note analysis showed that the majority of the elderly FTLD patients, like their younger counterparts, had behavioural features consistent with frontotemporal dementia. FTLD is common amongst elderly persons and all or most of the major clinical and histological subtypes present in younger individuals can be seen in the older group.

Entities:  

Mesh:

Year:  2010        PMID: 20978901     DOI: 10.1007/s00401-010-0765-z

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  32 in total

1.  Hippocampal Sclerosis in Older Patients: Practical Examples and Guidance With a Focus on Cerebral Age-Related TDP-43 With Sclerosis.

Authors:  Matthew D Cykowski; Suzanne Z Powell; Paul E Schulz; Hidehiro Takei; Andreana L Rivera; Robert E Jackson; Gustavo Roman; Gregory A Jicha; Peter T Nelson
Journal:  Arch Pathol Lab Med       Date:  2017-05-03       Impact factor: 5.534

Review 2.  Mechanisms of disease in frontotemporal lobar degeneration: gain of function versus loss of function effects.

Authors:  Glenda Halliday; Eileen H Bigio; Nigel J Cairns; Manuela Neumann; Ian R A Mackenzie; David M A Mann
Journal:  Acta Neuropathol       Date:  2012-08-10       Impact factor: 17.088

Review 3.  A clinicopathological approach to the diagnosis of dementia.

Authors:  Fanny M Elahi; Bruce L Miller
Journal:  Nat Rev Neurol       Date:  2017-07-14       Impact factor: 42.937

4.  Mixed TDP-43 proteinopathy and tauopathy in frontotemporal lobar degeneration: nine case series.

Authors:  Eun-Joo Kim; Jesse A Brown; Jersey Deng; Ji-Hye L Hwang; Salvatore Spina; Zachary A Miller; Mary G DeMay; Victor Valcour; Anna Karydas; Eliana Marisa Ramos; Giovanni Coppola; Bruce L Miller; Howard J Rosen; William W Seeley; Lea T Grinberg
Journal:  J Neurol       Date:  2018-10-15       Impact factor: 4.849

5.  Genetic Modifiers in Neurodegeneration.

Authors:  Nimansha Jain; Alice S Chen-Plotkin
Journal:  Curr Genet Med Rep       Date:  2018-02-05

6.  Efficacy of memantine on neuropsychiatric symptoms associated with the severity of behavioral variant frontotemporal dementia: A six-month, open-label, self-controlled clinical trial.

Authors:  Pan Li; Wei Quan; Yu-Ying Zhou; Yan Wang; Hui-Hong Zhang; Shuai Liu
Journal:  Exp Ther Med       Date:  2016-04-20       Impact factor: 2.447

Review 7.  Frontotemporal dementia.

Authors:  Jee Bang; Salvatore Spina; Bruce L Miller
Journal:  Lancet       Date:  2015-10-24       Impact factor: 79.321

8.  Role of brain infarcts in behavioral variant frontotemporal dementia: Clinicopathological characterization in the National Alzheimer's Coordinating Center database.

Authors:  Teresa Torralva; Luciano A Sposato; Patricia M Riccio; Ezequiel Gleichgerrcht; María Roca; Jon B Toledo; John Q Trojanowski; Walter A Kukull; Facundo Manes; Vladimir Hachinski
Journal:  Neurobiol Aging       Date:  2015-07-03       Impact factor: 4.673

9.  Increased expression of the frontotemporal dementia risk factor TMEM106B causes C9orf72-dependent alterations in lysosomes.

Authors:  Johanna I Busch; Travis L Unger; Nimansha Jain; R Tyler Skrinak; Rakshita A Charan; Alice S Chen-Plotkin
Journal:  Hum Mol Genet       Date:  2016-04-28       Impact factor: 6.150

10.  Hippocampal and mesial temporal sclerosis in early-onset frontotemporal lobar degeneration versus Alzheimer's disease.

Authors:  Aditi Joshi; Edmond Teng; Kanida Tassniyom; Mario F Mendez
Journal:  Am J Alzheimers Dis Other Demen       Date:  2013-10-01       Impact factor: 2.035

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.